| Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis … JM Kocarnik, K Compton, FE Dean, W Fu, BL Gaw, JD Harvey, ... JAMA oncology 8 (3), 420-444, 2022 | 1014 | 2022 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 406 | 2022 |
| Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 BS Sheena, L Hiebert, H Han, H Ippolito, M Abbasi-Kangevari, ... The lancet Gastroenterology & hepatology 7 (9), 796-829, 2022 | 297 | 2022 |
| Resveratrol and grape extract-loaded solid lipid nanoparticles for the treatment of Alzheimer’s disease JA Loureiro, S Andrade, A Duarte, AR Neves, JF Queiroz, C Nunes, ... Molecules 22 (2), 277, 2017 | 284 | 2017 |
| Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 R Sharma, M Abbasi-Kangevari, R Abd-Rabu, H Abidi, E Abu-Gharbieh, ... The lancet Gastroenterology & hepatology 7 (7), 627-647, 2022 | 236 | 2022 |
| Natural compounds for Alzheimer’s disease therapy: a systematic review of preclinical and clinical studies S Andrade, MJ Ramalho, JA Loureiro, MC Pereira International journal of molecular sciences 20 (9), 2313, 2019 | 196 | 2019 |
| Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer’s disease treatment JA Loureiro, B Gomes, G Fricker, MAN Coelho, S Rocha, MC Pereira Colloids and Surfaces B: Biointerfaces 145, 8-13, 2016 | 161 | 2016 |
| The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019 G Castelpietra, AKS Knudsen, EE Agardh, B Armocida, M Beghi, KM Iburg, ... The Lancet Regional Health–Europe 16, 2022 | 129 | 2022 |
| Resveratrol brain delivery for neurological disorders prevention and treatment S Andrade, MJ Ramalho, MC Pereira, JA Loureiro Frontiers in pharmacology 9, 404110, 2018 | 126 | 2018 |
| Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment MJ Ramalho, E Sevin, F Gosselet, J Lima, MAN Coelho, JA Loureiro, ... International journal of pharmaceutics 545 (1-2), 84-92, 2018 | 123 | 2018 |
| The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019 EM Alvarez, LM Force, R Xu, K Compton, D Lu, HJ Henrikson, ... The Lancet Oncology 23 (1), 27-52, 2022 | 122 | 2022 |
| Electron energy distributions and excitation rates in high-frequency argon discharges CM Ferreira, J Loureiro Journal of Physics D: Applied Physics 16 (12), 2471, 1983 | 121 | 1983 |
| Alzheimer’s disease: Development of a sensitive label-free electrochemical immunosensor for detection of amyloid beta peptide P Carneiro, J Loureiro, C Delerue-Matos, S Morais, M do Carmo Pereira Sensors and Actuators B: Chemical 239, 157-165, 2017 | 117 | 2017 |
| Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer's disease RGR Pinheiro, A Granja, JA Loureiro, MC Pereira, M Pinheiro, AR Neves, ... European Journal of Pharmaceutical Sciences 148, 105314, 2020 | 115 | 2020 |
| Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 HH Kyu, A Vongpradith, SB Sirota, A Novotney, CE Troeger, MC Doxey, ... The Lancet infectious diseases 22 (11), 1626-1647, 2022 | 106 | 2022 |
| Targeting nanoparticles across the blood–brain barrier with monoclonal antibodies JA Loureiro, B Gomes, MAN Coelho, M Carmo Pereira, S Rocha Nanomedicine 9 (5), 709-722, 2014 | 93 | 2014 |
| Electron transport parameters and excitation rates in argon CM Ferreira, J Loureiro Journal of Physics D: Applied Physics 16 (9), 1611, 1983 | 89 | 1983 |
| Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019 B Armocida, L Monasta, S Sawyer, F Bustreo, G Segafredo, ... The Lancet Child & Adolescent Health 6 (6), 367-383, 2022 | 84 | 2022 |
| Double optimization of rivastigmine-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery using the quality by design (QbD) approach: formulation variables and … S Cunha, CP Costa, JA Loureiro, J Alves, AF Peixoto, B Forbes, ... Pharmaceutics 12 (7), 599, 2020 | 76 | 2020 |
| RVG29-functionalized lipid nanoparticles for quercetin brain delivery and Alzheimer’s disease RGR Pinheiro, A Granja, JA Loureiro, MC Pereira, M Pinheiro, AR Neves, ... Pharmaceutical Research 37, 1-12, 2020 | 74 | 2020 |
